Trials / Completed
CompletedNCT00490711
Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer
Phase II Study of Sequential Therapy With Paclitaxel Plus Carboplatin Followed by Gemzar Plus Carboplatin in the Treatment of Patients With Epithelial Ovarian Cancer FIGO Stages III-IV
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of paclitaxel and carboplatin followed by gemcitabine and carboplatin therapy for patients with epithelial ovarian cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gemcitabine | |
| DRUG | carboplatin | |
| DRUG | paclitaxel |
Timeline
- Start date
- 2003-07-01
- Completion
- 2005-04-01
- First posted
- 2007-06-25
- Last updated
- 2007-06-25
Locations
1 site across 1 country: Slovakia
Source: ClinicalTrials.gov record NCT00490711. Inclusion in this directory is not an endorsement.